The National Comprehensive Cancer Network (NCCN) recommends that ovarian cancer patients should be initially treated with surgery and chemotherapy. Around 75 percent of women who receive this regimen go into remission. The standard of care includes a platinum drug, like carboplatin, a taxane, like paclitaxel (Taxol) and sometimes bevacizumab (Avastin) to inhibit blood vessel growth.
Treatments are based on the cancer stage and each patient’s individual needs. Some women diagnosed with stage I cancer localized to a single ovary may opt to only have that ovary and fallopian tube removed. This is sometimes called fertility-sparing surgery.
In some advanced stage III or IV disease, a surgeon will recommend chemotherapy before surgery (called neoadjuvant therapy) to reduce the size of the tumors so they can be removed more easily during the debulking surgery.
Please visit our treatment chart for more information about first-line options.